Company intelligence / Profile preview

QueenB

Ownership: Private
Development stage: Other

Overview

Qeen Biotechnologies develops and manufactures advanced bacteriophage solutions using a GMP-certified process. Their products are used to combat bacterial infections across pharmaceutical, agricultural, veterinary, and nutraceutical industries. The company emphasizes innovation in non-traditional therapeutics and offers tailored solutions for complex bacterial challenges.

Therapeutic areas: Infectious Diseases
Modalities: Bacteriophage therapyBiologic
Industry: Biotech

Beyond the preview

Go deeper on QueenB.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on QueenB.

Explore the full profile